Casa Sollievo della Sofferenza is a private scientific research hospital in San Giovanni Rotondo, Italy, founded by Saint Pio of Pietrelcina, and administered by Vatican City.

During the past decade, Ospedale Casa Sollievo della Sofferenza conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 47 clinical trials were completed, i.e. on average, 51.1% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 35 clinical trials were completed. i.e. 106.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Casa Sollievo della Sofferenza" #1 sponsor was "Celgene" with 9 trials, followed by "Gilead Sciences" with 9 trials sponsored, "Shire" with 9 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 7 trials sponsored and "Incyte Corporation" with 7 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Casa Sollievo della Sofferenza" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "IRCCS Azienda Ospedaliero-Universitaria di Bologna" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Azienda Ospedaliero-Universitaria Careggi" with 2 trials as a collaborator and "Clinical Research Technology S.r.l." with 2 trials as a collaborator. Other collaborators include 92 different institutions and companies that were collaborators in the rest 91 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Casa Sollievo della Sofferenza" are "Multiple Myeloma" (10 trials), "Ulcerative Colitis" (9 trials), "Crohn's Disease" (7 trials), "Colitis, Ulcerative" (4 trials) and "Diffuse Large B-cell Lymphoma" (4 trials). Many other conditions were trialed in "Ospedale Casa Sollievo della Sofferenza" in a lesser frequency.

Most popular intervention types in "Ospedale Casa Sollievo della Sofferenza" are "Drug" (114 trials), "Other" (17 trials), "Biological" (9 trials), "Procedure" (9 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Dexamethasone" (6 trials), "radiation therapy" (5 trials), "Bevacizumab" (4 trials) and "Bortezomib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Casa Sollievo della Sofferenza" are 143 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Casa Sollievo della Sofferenza". undefined are not yet recruiting, 23 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Ospedale Casa Sollievo della Sofferenza, undefined suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Casa Sollievo della Sofferenza, 1 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".